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Tetrahydrobiopterina b s t r a c t
Quinonoid dihydropteridine reductase (QDPR) catalyzes the regeneration of tetrahydrobiopterin
(BH4), a cofactor for monoamine synthesis, phenylalanine hydroxylation and nitric oxide produc-
tion. Here, we produced and analyzed a transgenic Qdpr/ mouse model. Unexpectedly, the BH4
contents in the Qdpr/mice were not decreased and even increased in some tissues, whereas those
of the oxidized form dihydrobiopterin (BH2) were signiﬁcantly increased. We demonstrated that
unlike the wild-type mice, dihydrofolate reductase regenerated BH4 from BH2 in the mutants. Fur-
thermore, we revealed wide alterations in folate-associated metabolism in the Qdpr/mice, which
suggests an interconnection between folate and biopterin metabolism in the transgenic mouse
model.
 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
6R-L-erythro-5,6,7,8-tetrahydrobiopterin (BH4), which is syn-
thesized from guanosine triphosphate (GTP) by GTP cyclohydrolase
I (GCH), is an essential cofactor for the hydroxylation of tyrosine
and tryptophan, which is the limiting step in dopamine and sero-
tonin synthesis, respectively [1]. Dopamine and serotonin are well
known to be involved in brain functions as neurotransmitters, and
consequently, monoamine deﬁciency due to BH4 depletion causes
a variety of neuropsychiatric disorders [2]. BH4 is essential for
phenylalanine hydroxylase, alkylglycerol mono-oxygenase
(AGMO) and all three isoforms of nitric oxide synthases (iNOS,
nNOS and eNOS) as well. In endothelial cells, it has beendemonstrated that BH4 modulates the coupling of eNOS, thereby
regulating the production of superoxide and the intracellular redox
state [3]. Quinonoid dihydropteridine reductase (QDPR) is responsi-
ble for the recycling of BH4 from quinonoid dihydrobiopterin
(qBH2), which is the product after BH4 fulﬁlls its cofactor role for
aromatic amino acid hydroxylation. Because qBH2 is unstable, eas-
ily converted to 7,8-dihydrobiopterin (BH2), alteration in the QDPR
activity would inﬂuence the oxidation state of BH4. The QDPR-deﬁ-
cient patients who have a nearly complete loss of enzyme activity
develop severe symptoms caused by BH4 and monoamine deﬁ-
ciencies [4].
Folate, which is one of the 13 essential vitamins for human
beings, is assumed to be related with BH4, because they have the
same pterin ring in their structures where redox reactions can
occur. Physiologically, the metabolism of two compounds seems
to be independent, nevertheless dihydrofolate reductase (DHFR),
which catalyzes the reduction of dihydrofolate (DHF) to tetrahy-
drofolate (THF), was reported to catalyze the reduction of BH2 in
several cell types [5,6]. In cultured endothelial cells, DHFR can
affect the BH4/BH2 ratio and consequently play a critical role in
eNOS reaction [7]. Furthermore, reports showed that the extremely
low activity of DHFR in human endothelial cells would limit
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role in the maintenance of intracellular BH4 levels [8].
To elucidate (1) how folate metabolism is affected by biopterins
and (2) how BH4 regeneration is regulated in vivo, we produced a
mouse model which has a genetic defect in the Qdpr gene. Here, we
report that the transgenic mouse model exhibited drastically
increased BH2 levels, unchanged or increased BH4 levels, and
therefore lowered BH4/BH2+BP ratio. Furthermore, we found that
the Qdpr/ mice presented wide alterations in folate-associated
metabolism in the liver. This is the ﬁrst report of a mouse model
of QDPR deﬁciency, which reveals the interconnection between
biopterin and folate metabolism in the absence of QDPR.
2. Materials and methods
2.1. Production of the Qdpr-deﬁcient mice
The Qdpr gene was inactivated by homologous recombination
targeting Exon 1. The knock-out mice were produced by Lexicon
Pharmaceuticals, Inc. (Woodlands, TX, USA) with 129SvEv-derived
ES cells. We established a C57BL/6J background line by repetitive
crossing. Mice were housed in temperature and humidity-con-
trolled cages with a 12-hour light–dark cycle and given free access
to water and food. All studies involving laboratory animals were
conducted in accordance with the Guidelines for the Care and
Use of Laboratory Animals of Tokyo Institute of Technology and
Fujita Health University. Details for genotyping are given in
Supplementary information.
2.2. Quantiﬁcation of pteridines, folates, homocysteine and
measurement of GCH activity
The Qdpr+/+ and Qdpr/ mice were sacriﬁced by cervical dislo-
cation, and tissues were immediately collected, frozen in liquid
nitrogen and stored at 80 C until analysis. Pteridines were quan-
tiﬁed by high-performance liquid chromatography (HPLC), using
the post-column oxidation method [9]. Folate derivatives were
measured by HPLC with amperometric detection [10]. The total
plasma homocysteine was measured with a commercially avail-
able enzymatic assay kit (Axis-Shield, Dundee, UK). GCH activity
was assayed following the previous protocol [11].
2.3. Methotrexate (MTX) injection of the Qdpr+/+ and Qdpr/ mice
MTX (No. 139-13571, Wako, Osaka, Japan) was freshly dis-
solved in phosphate-buffered saline (PBS), and a dose of 2 mg/kg
body weight was intraperitoneally injected into the Qdpr+/+ and
Qdpr/ mice at 3–4 months of age. The mice were sacriﬁced 2 h
after the injection, and tissues were dissected for pteridine mea-
surement. Blood samples were collected with heparin treatment,
and pteridine levels in the plasma were analyzed.
2.4. Metabolomic analysis
Metabolic proﬁling of the Qdpr/ and Qdpr+/+ mice at 10 weeks
of age was conducted using capillary electrophoresis time-of-ﬂight
mass spectrometry (CE-TOFMS, Agilent Technologies, Waldbronn,
Germany). Tissue samples were prepared following the protocol
previously described [12]. Instrument condition for the analysis
of cationic and anionic was described at [13,14]. Heat maps were
generated to visualize the difference of the metabolite concentra-
tions between the Qdpr/ and Qdpr+/+ mice. Pearson correlation
distance was used for clustering. Metabolite concentrations were
transferred to Z-score, and a red/green color scheme was used to
indicate increase/decrease in the relative levels of the metabolites.2.5. In vitro kinetic assay of DHFR
Human recombinant DHFR (D6566, Sigma–Aldrich, St. Louis,
MO, USA) was used for the enzyme inhibition study, which was
assayed using a DU730 UV/Vis spectrophotometer (Beckman Coul-
ter, Brea, CA, USA). The assays were initiated by the addition of
enzyme at t = 0, and absorbance was monitored at 340 nm with
10 s intervals for 4 min. The kinetic assays for DHFR were per-
formed at 27 C, in the presence of 100 lM NADPH (Oriental Yeast,
Tokyo, Japan) and several ﬁxed concentrations (0–32 lM) of sub-
strate dihydrofolate (D7006, Sigma–Aldrich, St. Louis, MO, USA)
in 100 lM Tris–HCl buffer (pH 7.4). Extinction coefﬁcient
11800 M1 cm1 was used for the calculation [15]. The kinetic
parameters Km and Vmax were evaluated by ﬁtting the Michaelis–
Menten equation by non-linear regression. For inhibition studies,
three concentrations (12.5, 25 and 50 lM) of BH2 (No. 37272,
Sigma–Aldrich, St. Louis, MO, USA) were added to the reaction mix-
ture. Lineweaver–Burk plot was used to calculate the inhibition
constant of BH2.3. Results
3.1. Generation of the transgenic Qdpr/ mouse model
Qdpr gene Exon 1 was targeted and replaced with the IRES-lacZ/
MC1neo cassette (Fig. 1A). Production of mutant mice was con-
ﬁrmed by RT-PCR and Western blot analysis (Fig. 1B and C), which
demonstrated the successful genetic disruption of the Qdpr gene.
The Qdpr/mutant mice were born in a ratio that was slightly less
than the expected ratio of Mendelian law. The number of mice for
each genotype was Qdpr+/+: Qdpr+/: Qdpr/ = 87:145:70 =
1:1.7:0.8. The Qdpr/ mice developed normally to adulthood and
showed no distinguishable differences in appearance.
We quantiﬁed the pteridine contents in the liver and brain of
the Qdpr+/+ and Qdpr/ mice. Surprisingly, BH4 levels were not
decreased in the liver (27.4 ± 4.0 and 33.9 ± 8.7 pmol/mg protein
for the Qdpr+/+ and Qdpr/ mice, respectively, P = 0.49) or brain
(4.48 ± 0.24 and 4.51 ± 0.09 pmol/mg protein for the Qdpr+/+ and
Qdpr/ mice, respectively, P = 0.90), even though the ablation of
QDPR diminished the recycling pathway of BH4. However, the con-
tents of BH2 and the fully oxidized form biopterin (BH2+BP) were
signiﬁcantly increased in the Qdpr/ mouse liver and brain, as
expected through defect in the reaction by QDPR (Fig. 1D and E).
3.2. Alteration in the pteridine levels and administration of MTX
In aromatic amino acid hydroxylation, the product qBH2 is
regenerated via a QDPR-mediated recycling pathway. However,
BH4 levels were not decreased in the Qdpr/mouse brain or liver,
indicating that BH4 was regenerated via an alternative pathway
and/or that the de novo synthesis of BH4 from GTP was increased.
We assayed the activity of GCH, the rate-limiting enzyme for de
novo synthesis in the liver and found no signiﬁcant alteration in
the Qdpr/ mice (0.032 ± 0.006 and 0.031 ± 0.002 pmol/mg pro-
tein/min in the Qdpr+/+ and Qdpr/ mice, respectively, P = 0.81).
We also quantiﬁed the levels of neopterin, an intermediate in
BH4 de novo synthesis in the wild-type and transgenic mice
(Table S1), and found that neopterin levels were signiﬁcantly ele-
vated in all the tested tissues. These data suggest an enhanced de
novo synthesis of BH4 in the Qdpr/ mice.
In order to investigate the existence of alternative recycling
pathways, we inhibited the DHFR activity with MTX. In vitro stud-
ies showed that DHFR has the activity of reducing BH2 to produce
BH4 [5,7], but the extent to which DHFR contributes to the intra-
cellular BH4 pool in vivo is not fully understood. Thus, we
Fig. 1. Schematic representation for the production of the Qdpr/mutant mice and the pteridine proﬁle in the mutant mice. (A) Part of Exon 1 of the Qdpr gene was replaced
by an IRES-LacZ/MC1neo cassette. On the schematic box shows the primers used for genotyping. (B) RT-PCR conﬁrmed the genotypes and (C) Western blot analysis proved a
total abrogation of QDPR expression in the Qdpr/mouse whole brain. (D and E) Pteridine quantiﬁcation shows that BH4 (open bar) was not decreased but oxidized BH2 and
biopterin (gray, closed bar) were increased in the Qdpr/ mouse liver (D) and brain (E). The values represent the mean ± S.E.M. n = 4–6 mice (D and E). The statistical
assessment was conducted with a two-way ANOVA to compare the Qdpr+/+ (WT) and Qdpr/ (KO) mice (⁄⁄, P < 0.01; ⁄⁄⁄, P < 0.001).
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activity with MTX (2 mg/kg body weight) via intraperitoneal injec-
tion (Fig. 2).
As can be seen from the comparison of WT-MTX and WT-PBS
columns, BH4 levels in the wild-type mice were relatively unaf-
fected by MTX, except the kidney showed a signiﬁcant decrease
(Fig. 2C). The levels of BH2 and BP were elevated in the liver
(0.98 ± 0.12 and 1.74 ± 0.19 pmol/mg protein for the Qdpr+/+ and
Qdpr/ mice, respectively, P = 0.005) and kidney (0.94 ± 0.11 and
2.85 ± 0.20 pmol/mg protein for the Qdpr+/+ and Qdpr/ mice,
respectively, P < 0.001). These results demonstrated that DHFR is
not or little responsible for the regeneration of BH4 in the
wild-type mice except in the kidney.
The Qdpr/ mice showed elevated levels of BH2 and BP in all
tested tissues without MTX treatment (KO-PBS columns in
Fig. 2), which indicated that QDPR plays an important role in the
regeneration of BH4 from qBH2 in these tissues. Unexpectedly,
the BH4 levels were greatly elevated in the Qdpr/ mouse kidney,
lung, heart and blood plasma (Fig. 2C–F). These increased BH4
turned out to be produced from the reduction of BH2 through
the action of DHFR, because the Qdpr/ mice treated with MTX
showed further elevated BH2+BP levels and drastically decreasedBH4 levels. These data revealed an in vivo involvement of DHFR
in the BH4 regeneration.
Additionally, we calculated the ratios of BH4 to BH2+BP, which
may reﬂect the redox state in the cells (Fig. 3). The ratios turned
out to be signiﬁcantly decreased by the absence of QDPR in most
tissues except the kidney. Administration of MTX to the wild-type
mice affected the ratio only in the kidney, while the administration
to the Qdpr/mice further decreased the ratio in all the tested tis-
sues. These results suggested that QDPR would be a major determi-
nant of the ratio BH4/BH2+BP in many tissues, whereas the ratio in
the kidney is affected by DHFR activity.
3.3. Folate contents and the metabolomic analysis in the Qdpr/ mice
Next, we quantiﬁed the contents of folate derivatives in order to
clarify the possible crosstalk between biopterin and folate metab-
olism. The Qdpr/mouse liver showed signiﬁcantly decreased lev-
els of THF (16.5 ± 1.2 and 5.8 ± 0.6 nmol/g tissue in the Qdpr+/+ and
Qdpr/mice, respectively, P < 0.001, Fig. 4A) and 5-methyltetrahy-
drofolate (5-MTHF, 3.7 ± 0.1 and 2.6 ± 0.2 nmol/g tissue in the
Qdpr+/+ and Qdpr/ mice, respectively, P = 0.0015, Fig. 4B), while
DHF showed no difference (0.31 ± 0.03 and 0.25 ± 0.07 nmol/g
Fig. 2. In vivo involvement of DHFR in BH4 regeneration. MTX (2 mg/kg body weight) or PBS was intraperitoneally injected into the Qdpr+/+ (WT) and Qdpr/ (KO) mice. After
2 h, brain (A), liver (B), kidney (C), lung (D), heart (E) and blood plasma (F) were collected for pteridine quantiﬁcation. BH4 is denoted as open bars and BH2+BP is denoted as
gray, closed bars. The values represent the mean ± S.E.M. n = 6 or 7 mice, except for the blood plasma in Panel F (n = 3 or 4 mice). The statistical assessment was conducted
with a two-tailed Student’s t-test. Asterisks (⁄) and octothorpes (#) indicate the signiﬁcance levels of the corresponding groups with the WT-PBS and KO-PBS groups,
respectively (#, P < 0.05; ⁄⁄ and ##, P < 0.01; ⁄⁄⁄ and ###, P < 0.001).
Fig. 3. Signiﬁcant alteration of the ratio BH4/BH2+BP by methotrexate (MTX) treatment. The ratio of BH4/BH2+BP was calculated in the brain (A), liver (B), kidney (C), lung
(D), heart (E) and blood plasma (F). Each dot represents one mouse sample and the bars represent the mean ± S.E.M. n = 6 or 7 mice except for blood plasma in Panel F (n = 3 or
4 mice). The statistical assessment was conducted using a two-tailed Student’s t-test. Asterisks (⁄) and octothorpes (#) indicate the signiﬁcance levels of the corresponding
groups with WT-PBS and KO-PBS groups, respectively. (⁄, P < 0.05; ⁄⁄ and ##, P < 0.01; ⁄⁄⁄ and ###, P < 0.001).
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Fig. 4C). We also quantiﬁed the folate derivatives in the brain
and kidney. 5-MTHF and DHF showed no signiﬁcant alteration,
whereas THF showed a slightly decreasing trend in the kidney(11.2 ± 0.8 and 9.4 ± 0.5 nmol/g tissue in the Qdpr+/+ and Qdpr/
mice, respectively, P = 0.08, Fig. 4G).
Folates are involved in amino acid and nucleic acid synthesis,
so we conducted global metabolic proﬁling using capillary
Fig. 4. Folate deﬁciency in the Qdpr/ mouse liver. Folate derivatives in the liver, brain and kidney were quantiﬁed by HPLC with amperometric detection. (A–C) Levels of
tetrahydrofolate (THF) and 5-methyltetrahydrofolate (5-MTHF) were decreased but those of dihydrofolate (DHF) showed no alteration in the Qdpr/ (KO) mouse liver. (D–I)
Levels of folate derivatives, including THF, 5-MTHF and DHF in the brain or kidney were not changed in the Qdpr/mice. The values represent the mean ± S.E.M. n = 6 mice.
The statistical assessment was conducted using a two-tailed Student’s t-test to compare WT and KO mice (⁄⁄, P < 0.01; ⁄⁄⁄, P < 0.001).
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see the consequential effects resulting from folate disturbance. In
the liver samples, a total of 252 metabolites were identiﬁed, of
which 21 compounds showed statistical difference (P < 0.05)
between the Qdpr+/+ and Qdpr/ mice (Table 1). A heat map was
constructed to represent the relative levels of these metabolites
(Fig. S1). Consistent with the aforementioned data, BH2 levels were
elevated in the Qdpr/ mice. Furthermore, the levels of metabo-
lites involved in folate metabolism, such as Gly, phosphorylcholine,
taurine, hypotaurine, gamma-Glu-Cys, reduced glutathione and
spermine, were all altered. Of note, some biomarkers of oxidative
stress showed signiﬁcant difference, such as gamma-Glu-Cys (a
biomarker of hepatic glutathione consumption [13]), spermine (a
natural polyamine which protects against oxidative stress as a pre-
cursor of the antioxidant glutathione [16]) and ophthalmate (a tri-
peptide analogue of GSH that is regarded as that functions also as a
free radical scavenger [17]).
We further quantiﬁed the homocysteine contents in the blood
plasma, which is regarded as a biomarker for oxidative stress. The
homocysteine levels were elevated by 40.9% in the Qdpr/ mice
at 40 weeks of age (8.6 ± 0.8 and 12.1 ± 1.0 lM in the Qdpr+/+ andQdpr/ mice, respectively, P = 0.026). However, the Qdpr+/+ and
Qdpr/ mice at 16 weeks of age showed no difference (8.0 ± 0.4
and 7.2 ± 1.1 lM, respectively, P = 0.51). Collectively, these data
revealed that defects in the Qdpr gene disturbed folate-associated
metabolism and resulted in the increased oxidative stress in the
Qdpr/ mouse liver.
3.4. Kinetics of dihydrofolate reduction by DHFR with BH2 inhibition
It puzzled us why folate metabolism was affected in the Qdpr/
mice. As previously mentioned, BH2 is a poor substrate for DHFR,
we assumed that the accumulated BH2 in the Qdpr/ mice may
inhibit the DHFR activity and lead to the inhibition of DHF reduc-
tion, because mammalian DHFR is a monomer with a single bind-
ing site for folate [18]. To corroborate this, we conducted enzyme
kinetic assays and calculated the kinetic parameters. DHFR activity
with DHF exhibited standard Michaelis–Menten kinetics (Fig. S2A),
and a Km of 1.554 ± 0.567 lM and a Vmax of 5.826 ± 0.514 lmol/
min/mg protein was obtained from a Hanes–Woolf plot
(Fig. S2B). Inhibition studies of human DHFR with BH2 yielded a
Ki value of 88.2 lM (Fig. S2C and D).
Table 1
A list of metabolites with signiﬁcant differences in the Qdpr+/+ and Qdpr/mouse liver. Average content of each metabolite (nmol/g tissue) in the liver of the Qdpr+/+ and Qdpr/
mice was calculated from the metabolomic analysis. The statistical assessment was conducted using a two-tailed Student’s t-test to compare the Qdpr+/+ (WT) and Qdpr/ (KO)
mice, and metabolites whose P value were less than 0.05 were sorted. The values are expressed as the mean ± S.E.M. n = 4 mice.
Metabolite Contents in the liver (nmol/g tissue) P Description of functions
WT KO
7,8-Dihydrobiopterin 34.62 ± 1.76 78.08 ± 5.57 0.0003 Oxidized form of BH4
gamma-Glu-Cys 24.16 ± 1.03 16.86 ± 0.63 0.0009 Precursor of GSH, inhibiting oxidative stress in
endothelial cells [16]
Phe 110.49 ± 8.74 420.74 ± 52.82 0.0012 Amino acid, converted to Tyr by PAH in hepatocytes
Gly 2049.05 ± 84.23 1538.51 ± 54.15 0.0022 Amino acid, involved in the folate metabolism
N-alpha-t-boc-asparagine 1.61 ± 0.20 3.58 ± 0.34 0.0024
N-epsilon-acetyl-lysine 1.86 ± 0.03 1.20 ± 0.07 0.0030
Ophthalmate 57.74 ± 5.11 134.78 ± 15.41 0.0032 Biomarker for oxidative stress where GSH is deﬁcient [13]
N-alpha benzoyl-L-arginine ethyl ester 0.23 ± 0.001 0.31 ± 0.003 0.0036 Vasodilatory property in rat isolated pulmonary artery [26]
Thiamine monophosphate 364.21 ± 21.99 564.98 ± 39.72 0.0045
Taurine 3048.34 ± 154.50 2077.71 ± 159.94 0.0047 Anti-oxidant and homocysteine derivative [27]
CMP 28.96 ± 1.60 38.01 ± 1.32 0.0048
Isethionate 10.20 ± 1.09 5.39 ± 0.90 0.0145 Taurine derivative [28]
Hypotaurine 321.44 ± 49.61 175.89 ± 10.84 0.0286 Precursor of taurine
Spermine 1.28 ± 0.09 1.96 ± 0.23 0.0303 Free radical scavenger [17]
Glucuronate 62.06 ± 6.76 83.75 ± 4.04 0.0332
N-Acetyl-phenylalanine 1.55 ± 0.25 2.91 ± 0.45 0.0386 Phe derivative
Tyr 109.98 ± 8.48 153.87 ± 14.59 0.0406 Amino acid
Glutathione (red) 5967.76 ± 486.73 3856.30 ± 656.90 0.0416 Anti-oxidant preventing damage to cellular components
caused by ROS
Phosphorylcholine 422.40 ± 85.82 205.85 ± 5.28 0.0454 Choline precursor
gamma-Butyrobetaine 10.64 ± 1.02 7.89 ± 0.43 0.0475 Precursor of L-carnitine
alpha-Lipoamide + 5-Methoxyindoleacetate 12.30 ± 1.00 8.62 ± 1.10 0.0477 Anti-oxidant and serotonin derivative, respectively [29]
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In the present study, we characterized a mouse model with a
genetic defect in the Qdpr gene, which codes for an enzyme cata-
lyzing the regeneration of BH4 from qBH2. Although patients with
QDPR deﬁciency develop severe symptoms like low birth weight,
tremors, microcephaly and hypotonia with a short life-span in
many cases [4], the Qdpr/ mice looked normal and they were
indistinguishable from their wild-type littermates in appearance.
Supporting the normal growth of the Qdpr/ mice, their BH4 con-
tents were unchanged, or rather increased in some tissues.
It is of great interestwhy BH4 levelswere elevated in theQdpr/
mouse tissues. It was reported that the total biopterin contents in
urine and cerebrospinal ﬂuids of QDPR-deﬁcient patients were ele-
vated probably due to compensation of lack of BH4 regeneration
[19]. In this study, we showed that the GCH activity was not
enhanced in the Qdpr/mice, although neopterin, an intermediate
in the BH4 de novo synthesis, showed signiﬁcant increase in many
tissues (Table S1). We inhibited the DHFR activity with MTX to
investigate the possibility that DHFR reduced BH2 to BH4. It turned
out that, although MTX did not alter the biopterin contents in the
wild-type mice except for the kidney, the levels of BH2+BP were
greatly increased and those of BH4 were decreased in the Qdpr/
mice. These data revealed the in vivo involvement of DHFR in BH4
regeneration, whichmaintains the BH4 pool in the absence of QDPR
enzyme. Additionally, the decline in the ratio of BH4/BH2+BP in the
Qdpr/mice (Fig. 3) suggests thatQDPR, rather thanDHFR regulates
the redox state of biopterins in the wild-type mouse tissues except
the kidney, although previous studies with cultured endothelial
cells revealed that DHFR affected the ratio of BH4 to BH2 and played
a critical role in eNOS reaction [7]. This inconsistency may come
from the different expression levels of QDPR and DHFR in each
tissue, which requires further investigation in the future.
It is not fully understoodwhy andhow total biopterin levelswere
greatly elevated in the tissues such as kidney and lung of theQdpr/
mice. We have found that the Qdpr/ mice developed mild
hyperphenylalaninemia implying dysfunction in phenylalaninehydroxylase in the liver (data not shown), which resembles the
symptoms of the QDPR-deﬁcient patients. However, there are some
difference in the symptoms between the Qdpr/ mice and the
patients. For instance, the QDPR-deﬁcient patients developedmuch
more severe BH4 deﬁciency while the Qdpr/mice did not. We are
inclined to think that the low activity of human DHFR would limit
BH4 regeneration, which has been corroborated in the human
endothelial cells [8]. Further studies are necessary for understand-
ing the availability of BH4 and the mechanism for uptake and
excretion of BH4.
Clinical cases have suggested that the phenotypes of folate and
biopterin deﬁciency overlap, but the mechanism of this relation-
ship has not been elucidated previously. A genetic defect in the
QDPR gene leads to folate deﬁciency in the brain [4], and an
inborn error of metabolism due to a defect in the DHFR gene
results in an insufﬁcient cerebral BH4 content [20]. Furthermore,
an ex vivo study demonstrates that 5-MTHF increased the vascu-
lar BH4 content and the ratio of BH4 versus total biopterin as a
strong peroxynitrite scavenger [21]. A growing body of evidence
points to a close relationship between folate and biopterin
metabolism.
Folate is associated with many important metabolic pathways
(Fig. S3), and metabolomic analysis conﬁrmed wide alterations in
the folate-associated metabolites in the Qdpr/ mice. Notably,
the levels of oxidative stress biomarkers, most of which are associ-
ated with folate and homocysteine metabolism also showed
signiﬁcant differences. Folate deﬁciency and the increase in homo-
cysteine have long been linked to the oxidative stress. Dietary
folate depletion and the consequent elevated plasma homocyste-
ine promoted hepatic oxidative stress and increased lipid peroxi-
dation in rats [22], and an in vitro study on human Hep G2 cells
cultivated in folate-deﬁcient media demonstrated that folate deﬁ-
ciency activated the redox-sensitive transcription factor NF-jB via
the homocysteine-dependent overproduction of hydrogen perox-
ide [23]. These ﬁndings conﬁrm the signiﬁcant correlation between
the folate deﬁciency and the increased oxidative stress in the
Qdpr/mice. Hyperhomocysteinemia is recognized as a signiﬁcant
3930 F. Xu et al. / FEBS Letters 588 (2014) 3924–3931risk factor for atherosclerosis, myocardial infarction, coronary
artery and cerebrovascular disease [24]. Thus, the elevation in
the plasma homocysteine levels suggests that the Qdpr/ mice
are susceptible to the cardiovascular diseases.
We speculated that disturbance in the folate metabolism of the
Qdpr/ mice might result from the inhibition of DHFR activity by
excess BH2. Kinetic assays demonstrated a mixed inhibition of BH2
on DHF reduction and the inhibition studies revealed a Ki value of
approx. 88 lM. On the other hand, based on the data we achieved
in Fig. 2B, the intracellular BH2 concentration, which was reported
to be approx. 0.4 ± 0.15 lM in cultured rat hepatocytes [25], is esti-
mated to be about 1.25 lM in the Qdpr/ mouse liver. This con-
centration is still much lower than the Ki value. Therefore, the
impaired DHF reduction seems not to be caused by the binding
competition between DHF and BH2. We also assessed the binding
afﬁnity through in silico molecular dynamics simulations, which
showed a lower binding afﬁnity of BH2 than DHF towards DHFR
(Fig. S4). These results imply that competitive inhibition of BH2
would be a less plausible explanation for the disturbed folate
metabolism in the Qdpr/ mice. Other possible causes for the
measured THF deﬁciency include that increased oxidative stress
in the Qdpr/mice decreases the amount of THF and/or that other
enzymes in the folate metabolism, such as methylenetetrahydrof-
olate reductase (MTHFR) are inﬂuenced by the increased BH2
levels.
In this study, using a genetically modiﬁed mouse model, we
elucidated the roles of DHFR and QDPR in BH4 regeneration, and
revealed that folate-associated metabolism was disturbed with
increased biochemical markers of oxidative stress. This is the ﬁrst
in vivo evidence that alteration in the biopterin metabolism affects
the folatemetabolism. Our investigation into the transgenicQdpr/
mouse model will ultimately beneﬁt our knowledge of oxidative
stress derived from folate and biopterin disturbances.
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